StockData
Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.03 (+1.79%)

Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –

Purple Biotech cash

Cash and short-term investments held at the end of each period.

Purple Biotech's cash was $8.72M at Dec 31, 2025. For fiscal 2025 it was $8.72M, up 17.8% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $15.03M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.72M+17.8%
FY2024Dec 31, 2024$7.40M-48.9%
FY2023Dec 31, 2023$14.49M-3.6%
FY2022Dec 31, 2022$15.03M+38.0%
FY2021Dec 31, 2021$10.89M-3.2%
FY2020Dec 31, 2020$11.25M+156.5%
FY2019Dec 31, 2019$4.39M-15.1%
FY2018Dec 31, 2018$5.16M+30.8%
FY2017Dec 31, 2017$3.95M-41.6%
FY2016Dec 31, 2016$6.76M-36.0%
FY2015Dec 31, 2015$10.56M+704.1%
FY2014Dec 31, 2014$1.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$8.72M-20.0%
Q4 FY2024Dec 31, 2024$7.40M-34.2%
Q4 FY2023Dec 31, 2023$14.49M+230.4%
Q4 FY2022Dec 31, 2022$15.03M+445.2%
Q4 FY2021Dec 31, 2021$10.89M+110.9%
Q4 FY2020Dec 31, 2020$11.25M+109.7%
Q4 FY2019Dec 31, 2019$4.39M+11.1%
Q2 FY2019Jun 30, 2019$2.76M+423.1%
Q4 FY2018Dec 31, 2018$5.16M-23.6%
Q2 FY2018Jun 30, 2018$5.36M-49.2%
Q4 FY2017Dec 31, 2017$3.95M+200.6%
Q2 FY2017Jun 30, 2017$527.00K–
Q4 FY2016Dec 31, 2016$6.76M–
Q4 FY2015Dec 31, 2015$10.56M–
Q4 FY2014Dec 31, 2014$1.31M–

More Purple Biotech figures

See a number that looks wrong?